Radiation Sterilization of Parenterals - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Radiation Sterilization of Parenterals
Irradiation is an established method of sterilization for pharmaceutical products. Radiation sterilization can be achieved with gamma rays, electron beams, and X-rays. Each of these techniques has its advantages and disadvantages. The author describes these methods, the ways to find the correct sterilization doses, and the regulatory and safety concerns about irradation sterilization.


Pharmaceutical Technology


4. Association of the British Pharmaceutical Industry, Use of Gamma Radiation Sources for the Sterilization of Pharmaceutical Products, (ABPI, London, 1960).

5. P.J. Geue, Radiosterilization of Pharmaceuticals, A Bibliography, 1962-1972, (Australian Atomic Energy Commission, Lucas Heights, Australia, 1973).

6. N.G.S. Gopal, "Radiation Sterilization of Pharmaceuticals and Polymers," Radiat. Phys. Chem. 12 (1), 35–50 (1978).

7. G.P. Jacobs, "A Review: Radiation Sterilization of Pharmaceuticals," Radiat. Phys.Chem. 26 (2), 133–142 (1985).

8. G.P. Jacobs, "A Review of the Effects of Gamma Radiation on Pharmaceutical Materials," J. Biomat. 10 (1), 59–96 (1995).

9. G.O. Phillips, "Medicines and Pharmaceutical Base Materials," in Manual on Radiation Sterilization of Medical and Biological Materials, (International Atomic Energy Agency, Vienna, 1973), pp. 207–228.

10. R. Schnell and W. Bogl, "Teil VI and VII, Bericht des Instituts fur Strahlenhygiene des Bundesgesundheitsamtes," in Der Einfluss der Strahlenbehandlung auf Artzneitmittel und Hilfstoffe. Eine Literaturstudie, (Dietrich Reimer Verlag, Berlin, 1984).

11. C. Schuttler, W. Bogl, and K. Stockhausen, "Teil II and III," in Der Einfluss der Strahlenbehandlung auf Artzneitmittel und Hilfstoffe. Eine Literaturstudie, (Dietrich Reimer Verlag, Berlin, 1979).

12. C. Schuttler and W. Bogl, "Teil IV and V," in Der Einfluss der Strahlenbehandlung auf Artzneitmittel und Hilfstoffe. Eine Literaturstudie, (Dietrich Reimer Verlag, Berlin, 1982).

13. H.Trutnau, W. Bog, and K. Stockhausen, "Teil I," in Der Einfluss der Strahlenbehandlung auf Artzneitmittel und Hilfstoffe. Eine Literaturstudie, (Dietrich Reimer Verlag, Berlin, 1978).

14. Ch. Zalewski, C. Schuttler, and W. Bogl, "Teil VIII," in Der Einfluss der Strahlenbehandlung auf Artzneitmittel und Hilfstoffe. Eine Literaturstudie, (Dietrich Reimer Verlag, Berlin, 1988).

15. C. Boess and W. Bogl, "Influence of Radiation Treatment on Pharmaceuticals—A Review: Alkaloids, Morphine Derivatives, and Antibiotics," Drug Dev. Ind. Pharm. 22 (6), 495–529 (1996).

16. P.A Wills, "Effects of Ionizing Radiation on Pharmaceuticals," Aust. J.Pharm. 44 (supp. 5), 550–557 (1963).

17. T.A. DuPlessis, The Radiation Sterilization of Pyrogen-Free Water in Polyethylene Sachets, (Atomic Energy Board, Pretoria, South Africa, Report PER-17-1, 1977).

18. N. Hilmy and S. Sadjirun, "Polyethylene Plastics as Containers for Water for Injection and as Material for Disposable Medical Devices Sterilized by Radiation," in Radiosterilization of Medical Products 1974 (International Atomic Energy Agency, Vienna, 1975), pp. 145–157.

19. G.P. Jacobs et al., "The Use of Gamma-Irradiation for the Sterilization of Water for Injections and Normal Saline Solution for Injection," Acta Pharma. Suec. 14 (3), 287–292 (1977).

20. G.P. Jacobs and E. Eisenberg, "The Reconstitution of Powders for Injection with Gamma-Irradiated Water," Intl. J. Appl. Radiat. Isotopes 32 (3), 180–181 (1981).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
9%
All of the above.
41%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Pharmaceutical Technology,
Click here